Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients

C Lass-Flörl1, G M Salzer, T Schmid

  • 1Department of Hygiene, Innsbruck University, Austria. cornelia.lass-flörl@uibk.ac.at

Insights

Pulmonary fungal colonization, including Aspergillus, was found in 63% of lung tissue samples. Eradicating fungal spores before chemotherapy is crucial for preventing invasive pulmonary aspergillosis.

Area of Science:

  • Medical Mycology
  • Pulmonary Medicine
  • Surgical Pathology

Background:

  • Pulmonary aspergillosis is a serious opportunistic infection.
  • Fungal colonization of the lungs can precede invasive disease.
  • Patients undergoing thoracic surgery and those with unexpected deaths represent distinct populations for studying lung fungal carriage.

Purpose of the Study:

  • To determine the prevalence of fungal colonization, specifically Aspergillus, in lung tissues from patients undergoing thoracic surgery and in autopsy samples.
  • To assess the significance of pre-existing fungal carriage in the context of potential pulmonary aspergillosis development.

Main Methods:

  • Analysis of lung tissue samples from 56 patients undergoing thoracic surgery.
  • Analysis of lung tissue samples from 18 individuals from an autopsy population.
  • Microbiological assessment for fungal growth and identification of Aspergillus species.

Main Results:

  • Overall, 63% of the 74 lung tissue samples showed evidence of pulmonary fungal colonization.
  • Fungal growth was detected in 62% of the surgery patient samples, with Aspergillus present in 39%.
  • In the autopsy population, 61% had fungal colonization, and Aspergillus was identified in 41% of cases.

Conclusions:

  • Pulmonary fungal colonization is prevalent in both surgical and autopsy lung tissue samples.
  • The findings underscore the necessity of eradicating resident fungal spores before initiating aggressive chemotherapy.
  • Preventing further fungal spore uptake during hospitalization is essential for mitigating the risk of pulmonary aspergillosis.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...